Observational studyBiomolecules & biomedicine2026
Clinical symptoms associated with prehospital delay in first-ever acute stroke.
Observational study in Biomolecules & biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early hospital arrival is essential for timely reperfusion therapy in acute stroke. This study aimed to identify clinical, symptom-related, and prehospital factors associated with delayed hospital arrival among patients with first-ever acute stroke, with particular focus on the 4.5-hour therapeutic window. This prospective single-center observational study was conducted at a comprehensive stroke center in Istanbul, Türkiye, between December 2023 and October 2024. Among 362 patients screened for suspected acute cerebrovascular events, 205 adults with first-ever acute ischemic stroke, intracerebral hemorrhage, or transient ischemic attack managed through the acute stroke pathway were included. Data were collected using a structured clinical form and a questionnaire on barriers to accessing acute stroke treatment, administered through face-to-face interviews with patients' relatives. Prehospital delay was defined as the interval from last known well (LKW) to hospital arrival. Patients were analyzed according to arrival within 1 hour, 2 hours, 3 hours, and 4.5 hours, using appropriate comparative statistical tests. The mean LKW-to-arrival time was 338.66 ± 345.67 minutes, with a median (IQR) of 240 (90-720) minutes. Overall, 29.3% of patients arrived within 1 hour, 41.0% within 2 hours, 48.3% within 3 hours, and 58.5% within 4.5 hours. Facial droop was consistently associated with earlier hospital arrival across multiple time thresholds (p ≤ 0.004), and syncope was more frequent among early presenters (p = 0.001). Conversely, visual symptoms were associated with delayed presentation, including vision loss after 3 hours and diplopia beyond 4.5 hours (p = 0.042 for both). Diabetes mellitus was associated with delayed arrival at the 1-hour and 2-hour thresholds, while hypertension was more common among patients arriving after 4.5 hours. Prehospital delay remains a substantial barrier to timely acute stroke care. Recognizable symptoms such as facial droop may facilitate earlier presentation, whereas less typical symptoms, particularly visual disturbances, may contribute to delayed arrival. These findings support locally tailored public awareness strategies and optimized prehospital stroke pathways that emphasize both typical and atypical stroke symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.